Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model

eLife

Volumn 4, Issue DECEMBER2015, 2015, Pages

  Zhao, Jie ^a   Siddiqui, Sarah ^a   Shang, Shaobin ^a   Bian, Yao ^a   Bagchi, Sreya ^a   He, Ying ^a   Wang, Chyung Ru ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1B ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 6; L SELECTIN; LIPOARABINOMANNAN; MYCOLIC ACID; TUMOR NECROSIS FACTOR; ZINC FINGER PROTEIN; BACTERIAL ANTIGEN; CD1 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LUNG GRANULOMA; MEDIASTINUM LYMPH NODE; MICROSCOPY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; TUBERCULOSIS; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SCID MOUSE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD1; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, SCID; MICE, TRANSGENIC; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 84983740011     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.08525     Document Type: Article

References (52)

1. Aagaard C, Hoang TTKT, Izzo A, Billeskov R, Troudt J, Arnett K, Keyser A, Elvang T, Andersen P, Dietrich J, Goletti D. 2009. Protection and polyfunctional t cells induced by Ag85B-TB10.4/IC31 against mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS One 4:5930 doi: 10.1371/journal.pone.0005930
2. Aagaard C, Dietrich J, Doherty M, Andersen P. 2009. TB vaccines: current status and future perspectives. Immunology and Cell Biology 87:279-286. doi: 10.1038/icb.2009.14
3. Adams EJ. 2014. Lipid presentation by human CD1 molecules and the diverse t cell populations that respond to them. Current Opinion in Immunology 26:1-6. doi: 10.1016/j.coi.2013.09.005
4. Azzam HS, DeJarnette JB, Huang K, Emmons R, Park C-S, Sommers CL, El-Khoury D, Shores EW, Love PE. 2001. Fine tuning of TCR signaling by CD5. The Journal of Immunology 166:5464-5472. doi: 10.4049/jimmunol.166.9.5464
5. Barral DC, Brenner MB. 2007. CD1 antigen presentation: how it works. Nature Reviews Immunology 7:929-941. doi: 10.1038/nri2191
6. Barry CE, Lee RE, Mdluli K, Sampson AE, Schroeder BG, Slayden RA, Yuan Y. 1998. Mycolic acids: structure, biosynthesis and physiological functions. Progress in Lipid Research 37:143-179. doi: 10.1016/S0163-7827(98)00008-3
7. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. 1994. Recognition of a lipid antigen by GDI-restricted a+ t cells. Nature 372:691-694. doi: 10.1038/372691a0
8. Bediako Y, Bian Y, Zhang H, Cho H, Stein PL, Wang C-R. 2012. SAP is required for the development of innate phenotype in H2-M3-restricted CD8+ t cells. The Journal of Immunology 189:4787-4796. doi: 10.4049/jimmunol.1200579
9. Behar SM, Dascher CC, Grusby MJ, Wang C-R, Brenner MB. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with mycobacterium tuberculosis. Journal of Experimental Medicine 189:1973-1980. doi: 10.1084/jem.189.12.1973
10. Behar SM. 2013. Antigen-specific CD8(+) t cells and protective immunity to tuberculosis. Advances in Experimental Medicine and Biology 783:141-163. doi: 10.1007/978-1-4614-6111-1_8
11. Bendelac A. 1995. Positive selection of mouse NK1+ t cells by CD1-expressing cortical thymocytes. Journal of Experimental Medicine 182:2091-2096. doi: 10.1084/jem.182.6.2091
12. Bendelac A, Savage PB, Teyton L. 2007. The biology of NKT cells. Annual Review of Immunology 25:297-336. doi: 10.1146/annurev.immunol.25.022106.141711
13. Chiu NM, Wang B, Kerksiek KM, Kurlander R, Pamer EG, Wang C-R. 1999. The selection of M3-restricted t cells is dependent on M3 expression and presentation of n-formylated peptides in the thymus. Journal of Experimental Medicine 190:1869-1878. doi: 10.1084/jem.190.12.1869
14. Cho H, Bediako Y, Xu H, Choi H-J, Wang C-R. 2011. Positive selecting cell type determines the phenotype of MHC class ib-restricted CD8+ t cells. Proceedings of the National Academy of Sciences of the United States of America 108:13241-13246. doi: 10.1073/pnas.1105118108
15. Chun T, Page MJ, Gapin L, Matsuda JL, Xu H, Nguyen H, Kang H-S, Stanic AK, Joyce S, Koltun WA, Chorney MJ, Kronenberg M, Wang C-R. 2003. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. Journal of Experimental Medicine 197:907-918. doi: 10.1084/jem.20021366
16. Coles MC, Raulet DH. 2000. NK1.1+ t cells in the liver arise in the thymus and are selected by interactions with class i molecules on CD4+CD8+ cells. The Journal of Immunology 164:2412-2418. doi: 10.4049/jimmunol.164.5.2412
17. Darrah PA, Patel DT, De Luca PM, Lindsay RWB, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, Roederer M, Seder RA. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against leishmania major. Nature Medicine 13:843-850. doi: 10.1038/nm1592
18. de Jong A, Pen˜ a-Cruz V, Cheng T-Y, Clark RA, Van Rhijn I, Moody DB. 2010. CD1a-autoreactive t cells are a normal component of the human a t cell repertoiree. Nature Immunology 11:1102-1109. doi: 10.1038/ni.1956
19. de Lalla C, Lepore M, Piccolo FM, Rinaldi A, Scelfo A, Garavaglia C, Mori L, De Libero G, Dellabona P, Casorati G. 2011. High-frequency and adaptive-like dynamics of human CD1 self-reactive t cells. European Journal of Immunology 41:602-610. doi: 10.1002/eji.201041211
20. De Libero G, Mori L. 2014. The t-cell response to lipid antigens of mycobacterium tuberculosis. Frontiers in Immunology 5:219 doi: 10.3389/fimmu.2014.00219
21. Dorhoi A, Kaufmann SHE. 2014. Perspectives on host adaptation in response to mycobacterium tuberculosis: modulation of inflammation. Seminars in Immunology 26:533-542. doi: 10.1016/j.smim.2014.10.002
22. Felio K, Nguyen H, Dascher CC, Choi H-J, Li S, Zimmer MI, Colmone A, Moody DB, Brenner MB, Wang C-R. 2009. CD1-restricted adaptive immune responses to mycobacteria in human group 1 CD1 transgenic mice. Journal of Experimental Medicine 206:2497-2509. doi: 10.1084/jem.20090898
23. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Annual Review of Immunology 19:93-129. doi: 10.1146/annurev.immunol.19.1.93
24. Gallegos AM, Pamer EG, Glickman MS. 2008. Delayed protection by ESAT-6-specific effector CD4+ t cells after airborne M. tuberculosis infection. Journal of Experimental Medicine 205:2359-2368. doi: 10.1084/jem.20080353
25. Gallegos AM, van Heijst JWJ, Samstein M, Su X, Pamer EG, Glickman MS, Ramakrishnan L. 2011. A gamma interferon independent mechanism of CD4 t cell mediated control of m. tuberculosis infection in vivo. PLoS Pathogens 7:1002052 doi: 10.1371/journal.ppat.1002052
26. Gilleron M. 2004. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted t cells during infection with mycobacterium tuberculosis. Journal of Experimental Medicine 199:649-659. doi: 10.1084/jem.20031097
27. Gong J, Stenger S, Zack JA, Jones BE, Bristol GC, Modlin RL, Morrissey PJ, Barnes PF. 1998. Isolation of mycobacterium-reactive CD1-restricted t cells from patients with human immunodeficiency virus infection. Journal of Clinical Investigation 101:383-389. doi: 10.1172/JCI318
28. Grant EP, Degano M, Rosat J-P, Stenger S, Modlin RL, Wilson IA, Porcelli SA, Brenner MB. 1999. Molecular recognition of lipid antigens by t cell receptors. Journal of Experimental Medicine 189:195-205. doi: 10.1084/jem.189.1.195
29. Hava DL, van der Wel N, Cohen N, Dascher CC, Houben D, Leon L, Agarwal S, Sugita M, van Zon M, Kent SC, Shams H, Peters PJ, Brenner MB, et al. 2008. Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation. Proceedings of the National Academy of Sciences of the United States of America 105:11281-11286. doi: 10.1073/pnas.0804681105
30. Karakousis PC, Bishai WR, Dorman SE. 2004. Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cellular Microbiology 6:105-116. doi: 10.1046/j.1462-5822.2003.00351.x
31. Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, Chua K, Eidson M, Kim H-J, Im JS, Pandolfi PP, Sant’Angelo DB. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer t cell effector functions. Nature Immunology 9:1055-1064. doi: 10.1038/ni.1641
32. Layre E, Collmann A, Bastian M, Mariotti S, Czaplicki J, Prandi J, Mori L, Stenger S, De Libero G, Puzo G, Gilleron M. 2009. Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted t cells. Chemistry & Biology 16:82-92. doi: 10.1016/j.chembiol.2008.11.008
33. Li S, Choi H-J, Felio K, Wang C-R. 2011. Autoreactive CD1b-restricted t cells: a new innate-like t-cell population that contributes to immunity against infection. Blood 118:3870-3878. doi: 10.1182/blood-2011-03-341941
34. Montamat-Sicotte DJ, Millington KA, Willcox CR, Hingley-Wilson S, Hackforth S, Innes J, Kon OM, Lammas DA, Minnikin DE, Besra GS, Willcox BE, Lalvani A. 2011. A mycolic acid-specific CD1-restricted t cell population contributes to acute and memory immune responses in human tuberculosis infection. Journal of Clinical Investigation 121:2493-2503. doi: 10.1172/JCI46216
35. Moody DB. 2000. CD1b-mediated t cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. Journal of Experimental Medicine 192:965-976. doi: 10.1084/jem.192.7.965
36. Moody DB, Ulrichs T, Mühlecker W, Young DC, Gurcha SS, Grant E, Rosat J-P, Brenner MB, Costello CE, Besra GS, Porcelli SA. 2000. CD1c-mediated t-cell recognition of isoprenoid glycolipids in mycobacterium tuberculosis infection. Nature 404:884-888. doi: 10.1038/35009119
37. Ottenhoff THM, Kaufmann SHE, Chitnis CE. 2012. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathogens 8:1002607 doi: 10.1371/journal.ppat.1002607
38. Reba SM, Li Q, Onwuzulike S, Ding X, Karim AF, Hernandez Y, Fulton SA, Harding CV, Lancioni CL, Nagy N, Rodriguez ME, Wearsch PA, Rojas RE. 2014. TLR2 engagement on CD4(+) t cells enhances effector functions and protective responses to mycobacterium tuberculosis. European Journal of Immunology 44:1410-1421. doi: 10.1002/eji.201344100
39. Reiley WW, Calayag MD, Wittmer ST, Huntington JL, Pearl JE, Fountain JJ, Martino CA, Roberts AD, Cooper AM, Winslow GM, Woodland DL. 2008. ESAT-6-specific CD4 t cell responses to aerosol mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proceedings of the National Academy of Sciences of the United States of America 105:10961-10966. doi: 10.1073/pnas.0801496105
40. Rothchild AC, Jayaraman P, Nunes-Alves C, Behar SM, Lewinsohn DM. 2014. INKT cell production of GM-CSF controls mycobacterium tuberculosis. PLoS Pathogens 10:1003805 doi: 10.1371/journal.ppat.1003805
41. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM, Flynn JL. 2008. Innate invariant NKT cells recognize mycobacterium tuberculosis-infected macrophages, produce interferon-g, and kill intracellular bacteria. PLoS Pathogens 4:1000239 doi: 10.1371/journal.ppat.1000239
42. Savage AK, Constantinides MG, Han J, Picard D, Martin E, Li B, Lantz O, Bendelac A. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29:391-403. doi: 10.1016/j.immuni.2008.07.011
43. Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, Hagens K, Modlin RL, Brinkmann V, Kaufmann SHE. 2003. Apoptosis facilitates antigen presentation to t lymphocytes through MHC-i and CD1 in tuberculosis. Nature Medicine 9:1039-1046. doi: 10.1038/nm906
44. Torrado E, Cooper AM, Ramakrishnan L. 2011. What do we really know about how CD4 t cells control mycobacterium tuberculosis? PLoS Pathogens 7:1002196 doi: 10.1371/journal.ppat.1002196
45. Ulrichs T, Moody DB, Grant E, Kaufmann SHE, Porcelli SA. 2003. T-cell responses to CD1-presented lipid antigens in humans with mycobacterium tuberculosis infection. Infection and Immunity 71:3076-3087. doi: 10.1128/IAI.71.6.3076-3087.2003
46. Van Rhijn I, Ly D, Moody DB. 2013. CD1a, CD1b, and CD1c in immunity against mycobacteria. Advances in Experimental Medicine and Biology 783:181-197. doi: 10.1007/978-1-4614-6111-1_10
47. Vincent MS, Xiong X, Grant EP, Peng W, Brenner MB. 2005. CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. The Journal of Immunology 175:6344-6351. doi: 10.4049/jimmunol.175.10.6344
48. Wolf AJ, Linas B, Trevejo-Nunez GJ, Kincaid E, Tamura T, Takatsu K, Ernst JD. 2007. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. The Journal of Immunology 179: 2509-2519. doi: 10.4049/jimmunol.179.4.2509
49. Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, Takatsu K, Ernst JD. 2008. Initiation of the adaptive immune response to mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. Journal of Experimental Medicine 205:105-115. doi: 10.1084/jem.20071367
50. Woodworth JSM, Behar SM. 2006. Mycobacterium tuberculosis-specific CD8+ t cells and their role in immunity. Critical Reviews in Immunology 26:317-352. doi: 10.1615/CritRevImmunol.v26.i4.30
51. Woodworth JS, Wu Y, Behar SM. 2008. Mycobacterium tuberculosis-specific CD8+ t cells require perforin to kill target cells and provide protection in vivo. The Journal of Immunology 181:8595-8603. doi: 10.4049/jimmunol.181.12.8595
52. Zhumabekov T, Corbella P, Tolaini M, Kioussis D. 1995. Improved version of a human CD2 minigene based vector for t cell-specific expression in transgenic mice. Journal of Immunological Methods 185:133-140. doi: 10.1016/0022-1759(95)00124-S